Drug Trial Radar · NCT04685226
A Phase I/II Clinical Trial of ICP-723 in the Treatment of Advanced Solid Tumors
Last checked: Nov 19, 2026Latest source record: Sep 2, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
310
Planned (sponsor's estimate)
Start
Sep 27, 2020
Primary completion
Jan 25, 2028
Study completion Feb 25, 2028
Sponsor
- Lead sponsor
- Beijing InnoCare Pharma Tech Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Dec 28, 2020
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 12 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A Multicenter, Nonrandomized, Open-Label Phase I/IIClinical Trial to Evaluate the Safety, Tolerability, and Pharmacokinetics of ICP-723 in Patients with Solid Tumors
Conditions
- Solid Tumors
Interventions
ICP-723Drug
ICP-723 is a white, round, uncoated table
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of Treatment-Emergent Adverse Events [Safety and Tolerability]Time frame: Up to 12 months
- MTDTime frame: Up to 2 Months
Locations
24 sites in 1 country. Site status is shown where the registry gives one.
The Second Affiliated Hospital of Anhui Medical University
Hefei, Anhui, China · Recruiting
Peking University Cancer Hospital
Beijing, Beijing Municipality, China · Recruiting
The First Medical Center of the Chinese People's Liberation Army General Hospital
Beijing, Beijing Municipality, China · Recruiting
Cancer Hospital Affiliated to Guangzhou Medical University
Guangzhou, Guangdong, China · Recruiting
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Guangzhou, Guangdong, China · Recruiting
The Fifth Affiliated Hospital of Sun Yat-sen University
Zhuhai, Guangdong, China · Recruiting
Sun Yat-Sen University Cancer Center
Guangdong, Guangzhou, China · Recruiting
Shijiazhuang People's Hospital
Shijiazhuang, Hebei, China · Recruiting
Cancer Hospital Affiliated to Harbin Medical University
Harbin, Heilongjiang, China · Recruiting
The First Affiliated Hospital of Henan University of Science and Technology
Luoyang, Henan, China · Recruiting
Henan Cancer Hospital
Zhengzhou, Henan, China · Recruiting
Henan Provincial People's Hospital
Zhengzhou, Henan, China · Recruiting
The First Affiliated Hospital of Zhengzhou University
Zhengzhou, Henan, China · Recruiting
Union Hospital, Tongji Medical College,Huazhong University of Science and Technology
Wuhan, Hubei, China · Recruiting
Hunan Cancer hospital
Changsha, Hunan, China · Recruiting
Jiangsu Provincial People's Hospital
Nanjing, Jiangsu, China · Recruiting
Affiliated Hospital of Jiangnan University
Wuxi, Jiangsu, China · Recruiting
The First Affiliated Hospital of Nanchang University
Nanchang, Jiangxi, China · Recruiting
Affiliated Cancer Hospital of Shandong First Medical University
Jinan, Shandong, China · Recruiting
Affiliated Hospital of Qingdao University
Qingdao, Shandong, China · Recruiting
Shanxi Cancer Hospital
Taiyuan, Shanxi, China · Recruiting
Yunnan Cancer Hospital
Kunming, Yunnan, China · Recruiting
Zhejiang Cancer Hospital
Hangzhou, Zhejiang, China · Recruiting
The first affiliated hospital Zhejiang university school of medicine
Hangzhou, Zhejiang, China · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.